$CHCI
Comstock Holding Companies, Inc.

2024 Q3 Form 10-Q Financial Statement

#000129996924000033 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $13.00M
YoY Change -10.15%
Cost Of Revenue $9.583M
YoY Change 11.99%
Gross Profit $3.412M
YoY Change -42.23%
Gross Profit Margin 26.26%
Selling, General & Admin $507.0K
YoY Change -11.83%
% of Gross Profit 14.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $77.00K
YoY Change -23.0%
% of Gross Profit 2.26%
Operating Expenses $507.0K
YoY Change -11.83%
Operating Profit $2.828M
YoY Change -46.21%
Interest Expense $94.00K
YoY Change -147.0%
% of Operating Profit 3.32%
Other Income/Expense, Net $23.00K
YoY Change 2200.0%
Pretax Income $2.945M
YoY Change -41.3%
Income Tax $568.0K
% Of Pretax Income 19.29%
Net Earnings $2.377M
YoY Change -49.26%
Net Earnings / Revenue 18.29%
Basic Earnings Per Share
Diluted Earnings Per Share $0.23
COMMON SHARES
Basic Shares Outstanding 9.864M shares
Diluted Shares Outstanding 10.33M shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.05M
YoY Change 93.13%
Cash & Equivalents $21.05M
Short-Term Investments
Other Short-Term Assets $402.0K
YoY Change 34.0%
Inventory
Prepaid Expenses
Receivables $7.361M
Other Receivables $0.00
Total Short-Term Assets $28.81M
YoY Change 29.83%
LONG-TERM ASSETS
Property, Plant & Equipment $6.792M
YoY Change -10.63%
Goodwill
YoY Change
Intangibles $144.0K
YoY Change 0.0%
Long-Term Investments $6.176M
YoY Change 2.93%
Other Assets $10.22M
YoY Change -52.9%
Total Long-Term Assets $23.35M
YoY Change -4.67%
TOTAL ASSETS
Total Short-Term Assets $28.81M
Total Long-Term Assets $23.35M
Total Assets $52.16M
YoY Change 11.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $910.0K
YoY Change -9.0%
Accrued Expenses $9.095M
YoY Change -14.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.420M
YoY Change -12.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $472.0K
YoY Change
Total Long-Term Liabilities $472.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.420M
Total Long-Term Liabilities $472.0K
Total Liabilities $10.48M
YoY Change -9.15%
SHAREHOLDERS EQUITY
Retained Earnings -$158.1M
YoY Change -3.72%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.69M
YoY Change
Total Liabilities & Shareholders Equity $52.16M
YoY Change 11.73%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $2.377M
YoY Change -49.26%
Depreciation, Depletion And Amortization $77.00K
YoY Change -23.0%
Cash From Operating Activities $3.872M
YoY Change 93.6%
INVESTING ACTIVITIES
Capital Expenditures $111.0K
YoY Change 11.0%
Acquisitions
YoY Change
Other Investing Activities -$79.00K
YoY Change
Cash From Investing Activities -$190.0K
YoY Change 90.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -62.00K
YoY Change
NET CHANGE
Cash From Operating Activities 3.872M
Cash From Investing Activities -190.0K
Cash From Financing Activities -62.00K
Net Change In Cash 3.620M
YoY Change 90.53%
FREE CASH FLOW
Cash From Operating Activities $3.872M
Capital Expenditures $111.0K
Free Cash Flow $3.761M
YoY Change 97.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address City Or Town
EntityAddressCityOrTown
Reston
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5368000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6549000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
568000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
332000 usd
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.43
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.61
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
205000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2377000 usd
CY2024Q3 chci Incentive Fee Revenue
IncentiveFeeRevenue
0 usd
dei Entity Shell Company
EntityShellCompany
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001299969
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Comstock Holding Companies, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1164345
dei Entity Address Address Line2
EntityAddressAddressLine2
10th Floor
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20190
dei City Area Code
CityAreaCode
703
dei Local Phone Number
LocalPhoneNumber
230-1985
dei Trading Symbol
TradingSymbol
CHCI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18788000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
402000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
353000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
28814000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
24386000 usd
CY2024Q3 chci Property Plant And Equipment Net Excluding Leasehold Improvements
PropertyPlantAndEquipmentNetExcludingLeaseholdImprovements
587000 usd
CY2023Q4 chci Property Plant And Equipment Net Excluding Leasehold Improvements
PropertyPlantAndEquipmentNetExcludingLeaseholdImprovements
478000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
144000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
144000 usd
CY2024Q3 chci Leasehold Improvements Net
LeaseholdImprovementsNet
67000 usd
CY2023Q4 chci Leasehold Improvements Net
LeaseholdImprovementsNet
89000 usd
CY2024Q3 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
6176000 usd
dei Entity File Number
EntityFileNumber
1-32375
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
7077000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6138000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6790000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9750000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10885000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5017000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10082000 shares
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.49
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.59
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-62000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33705000 usd
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value
CY2024Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
470000 usd
CY2023Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
53000 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
18000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
37000 usd
CY2024Q3 us-gaap Assets
Assets
52164000 usd
CY2023Q4 us-gaap Assets
Assets
49939000 usd
CY2024Q3 chci Accrued Personnel Costs
AccruedPersonnelCosts
2605000 usd
CY2023Q4 chci Accrued Personnel Costs
AccruedPersonnelCosts
4681000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
910000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
838000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
905000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
854000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4420000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6373000 usd
CY2024Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
472000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
77000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5585000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6273000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
10477000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
12723000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202348000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202112000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
86000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
86000 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2662000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2662000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
41687000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
37216000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52164000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49939000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12995000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-158097000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14463000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34386000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
9583000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
8557000 usd
us-gaap Cost Of Revenue
CostOfRevenue
27375000 usd
us-gaap Cost Of Revenue
CostOfRevenue
24561000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
507000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
575000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1588000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1711000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
77000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
74000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
218000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
212000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
10167000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
9206000 usd
us-gaap Costs And Expenses
CostsAndExpenses
29181000 usd
us-gaap Costs And Expenses
CostsAndExpenses
26484000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2828000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5257000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5205000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
7221000 usd
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
169000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
476000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2024Q3 chci Change In Fair Value Of Equity Method Investment
ChangeInFairValueOfEquityMethodInvestment
75000 usd
CY2023Q3 chci Change In Fair Value Of Equity Method Investment
ChangeInFairValueOfEquityMethodInvestment
241000 usd
chci Change In Fair Value Of Equity Method Investment
ChangeInFairValueOfEquityMethodInvestment
369000 usd
chci Change In Fair Value Of Equity Method Investment
ChangeInFairValueOfEquityMethodInvestment
720000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
56000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2945000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1135000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
635000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4685000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4233000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
5914000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9864000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9647000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9830000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9621000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10329000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10130000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10278000 shares
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.24
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.23
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.46
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.41
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
37216000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-444000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
1900 Reston Metro Plaza
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21051000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-162330000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33705000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2377000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
246000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
910000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
37928000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
290000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
946000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
39167000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
41687000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
28854000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-293000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
238000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
754000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
29553000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
800000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1000000.0 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-96000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
266000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
475000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
30198000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
273000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
4685000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
35156000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4233000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
5914000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
218000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
212000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
741000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
777000 usd
chci Gain Loss On Equity Method Investments Carried At Fair Value
GainLossOnEquityMethodInvestmentsCarriedAtFairValue
-369000 usd
chci Gain Loss On Equity Method Investments Carried At Fair Value
GainLossOnEquityMethodInvestmentsCarriedAtFairValue
-720000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
14000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
44000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1135000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-635000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
58000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
chci Gain Loss On Deferred Compensation Plan Assets
GainLossOnDeferredCompensationPlanAssets
1000 usd
chci Gain Loss On Deferred Compensation Plan Assets
GainLossOnDeferredCompensationPlanAssets
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2116000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7157000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
43000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2076000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1733000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
72000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
233000 usd
chci Increase Decrease In Deferred Compensation Plan Liabilities
IncreaseDecreaseInDeferredCompensationPlanLiabilities
348000 usd
chci Increase Decrease In Deferred Compensation Plan Liabilities
IncreaseDecreaseInDeferredCompensationPlanLiabilities
0 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-15000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-36000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2905000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-362000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
49000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
89000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
586000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
335000 usd
chci Payments For Deferred Compensation Plan Securities
PaymentsForDeferredCompensationPlanSecurities
371000 usd
chci Payments For Deferred Compensation Plan Securities
PaymentsForDeferredCompensationPlanSecurities
0 usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
305000 usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
281000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-139000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
58000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
561000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
390000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-503000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-390000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2263000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-787000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18788000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11722000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21051000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10935000 usd
us-gaap Interest Paid Net
InterestPaidNet
418000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9000 usd
CY2024Q3 chci Number Of Subsidiaries
NumberOfSubsidiaries
4 subsidiary
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Significant items subject to such estimates include, but are not limited to, the valuation of equity method investments, incentive fee revenue recognition, and the valuation of deferred tax assets. Assumptions made in the development of these estimates contemplate both the macroeconomic landscape and the Company's anticipated results, however actual results may differ materially from these estimates.</span></div>
CY2024Q3 us-gaap Real Estate Investments Joint Ventures
RealEstateInvestmentsJointVentures
6176000 usd
CY2023Q4 us-gaap Real Estate Investments Joint Ventures
RealEstateInvestmentsJointVentures
7077000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
297000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
297000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
890000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
890000 usd
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
97000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
109000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
294000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
348000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
394000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
406000 usd
us-gaap Lease Cost
LeaseCost
1184000 usd
us-gaap Lease Cost
LeaseCost
1238000 usd
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
395000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
391000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1170000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1191000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0464
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
292000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1194000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1222000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1203000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1233000 usd
CY2024Q3 chci Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
2336000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7480000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
990000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6490000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
116000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.07
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
192000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
19000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
97000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.09
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M12D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
667000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
97000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.09
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
667000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12995000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14463000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34386000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33705000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12995000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14463000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34386000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33705000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12995000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14463000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34386000 usd
CY2024Q3 chci Number Of Operating Assets Related To Triggering Events
NumberOfOperatingAssetsRelatedToTriggeringEvents
7 asset
CY2024Q3 chci Incentive Fee Leased Rate
IncentiveFeeLeasedRate
0.85
chci Incentive Fee Revenue
IncentiveFeeRevenue
0 usd
CY2023Q3 chci Incentive Fee Revenue
IncentiveFeeRevenue
4800000 usd
chci Incentive Fee Revenue
IncentiveFeeRevenue
4800000 usd
CY2023Q3 chci Number Of Operating Assets Related To Triggering Events
NumberOfOperatingAssetsRelatedToTriggeringEvents
3 asset
CY2023Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1400000 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1400000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2377000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4685000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4233000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
5914000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9864000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9647000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9830000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9621000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
465000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
483000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
448000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
461000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10329000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10130000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10278000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10082000 shares
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.24
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.49
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.43
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.61
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.23
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.46
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.41
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.59
CY2024Q3 chci Number Of Operating Assets Related To Triggering Events
NumberOfOperatingAssetsRelatedToTriggeringEvents
7 asset
CY2024Q3 chci Incentive Fee Leased Rate
IncentiveFeeLeasedRate
0.85
CY2024Q3 chci Operating Lease Termination Fee Percent
OperatingLeaseTerminationFeePercent
0.0350
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001299969-24-000033-index-headers.html Edgar Link pending
0001299969-24-000033-index.html Edgar Link pending
0001299969-24-000033.txt Edgar Link pending
0001299969-24-000033-xbrl.zip Edgar Link pending
chci-20240930.htm Edgar Link pending
chci-20240930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q324form10-qxex311.htm Edgar Link pending
q324form10-qxex312.htm Edgar Link pending
q324form10-qxex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
chci-20240930_cal.xml Edgar Link unprocessable
chci-20240930_def.xml Edgar Link unprocessable
chci-20240930_lab.xml Edgar Link unprocessable
chci-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chci-20240930_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending